Madden Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Madden Securities’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.79K	Buy	+33	New	+$1.48K	﹤0.01%	332
2023 Q1	–	Sell	-2,077	Closed	-$58.6K	–	108
2022 Q4	$58.6K	Buy	+2,077	New	+$65.9K	0.03%	187
2021 Q4	–	Sell	-9,452	Closed	-$706K	–	113
2021 Q3	$706K	Buy	9,452 +6,220	+192%	+$522K	0.38%	59
2021 Q2	$299K	Buy	3,232 +387	+14%	+$32.9K	0.16%	114
2021 Q1	$252K	Buy	+2,845	New	+$282K	0.15%	121

Other funds holding ARKG

NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return

Midwest Financial Partners Investments St. Cloud, Minnesota $260M AUM 10.89% 1-Year Est. Return

Canal Insurance Company Greenville, South Carolina $426M AUM 30.47% 1-Year Est. Return

Gimbal Financial Carmel, Indiana $172M AUM

Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

Global View Capital Management Waukesha, Wisconsin $449M AUM 34.17% 1-Year Est. Return

Brookstone Capital Management Wheaton, Illinois $10.1B AUM 17.94% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.18B AUM 13.12% 1-Year Est. Return

Madden Securities's ARKG Position: Q3 2026 in Review

Madden Securities opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 33 shares worth $1.79K. The stake represents ﹤0.01% of the portfolio and ranks #332 among its holdings. This is a return to the name: Madden Securities previously reported a position in ARKG as recently as Q4 2022.

Madden Securities first reported a position in ARKG in Q1 2021 and has held it in 5 quarters since. The position peaked at $706K in Q3 2021. 102 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

Madden Securities held 33 shares of ARK Genomic Revolution ETF worth $1.79K as of Q3 2026.
ARK Genomic Revolution ETF was a new Madden Securities position in Q3 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Madden Securities's portfolio in Q3 2026, its #332 holding.
Madden Securities first reported a position in ARK Genomic Revolution ETF in Q1 2021 and has held it in 5 quarters since.
Madden Securities's ARK Genomic Revolution ETF position peaked at $706K in Q3 2021.
102 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on Madden Securities's 13F filing for Q3 2026, filed 27 Oct 2026.